Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study.

Matthew RoughleyAlyshah Abdul SultanLorna ClarsonSara MullerRebecca WhittleJohn BelcherChristian D MallenEdward Roddy

Published in: Arthritis research & therapy (2018)

This study has demonstrated gout to be a risk factor for incident CKD stage ≥ 3. Further research examining the mechanisms by which gout may increase risk of CKD and whether optimal use of ULT can reduce the risk or progression of CKD in gout is suggested.

Keyphrases

chronic kidney disease
uric acid
end stage renal disease
metabolic syndrome
cardiovascular disease
type diabetes
stem cells